Downloading...
FORMYCON FLN 25/29FORMYCON FLN 25/29FORMYCON FLN 25/29

FORMYCON FLN 25/29

No trades
See on Supercharts

Key terms


Outstanding amount
‪70.00 M‬ EUR
Face value
1,000.00 EUR
Minimum denomination
100,000.00 EUR
Coupon
8.94% (Variable)
Coupon frequency
Quarterly
Yield to maturity
8.77%
Maturity date
Jul 9, 2029
Term to maturity
3 years

About FORMYCON FLN 25/29


Sector
Health Technology
Industry
Pharmaceuticals: Major
Home page
Issue date
Jul 9, 2025
ISIN
NO0013586024
FIGI
BBG01VT3FMZ9
Formycon AG engages in the manufacture of biosimilar drugs and formulations. Its product candidates include FYB201, FYB202, FYB203, and FYB205, which focuses in the opthalmology and immunology disease areas. The company was founded by Friedrich Wilhelm Steinweg and Nicolas Combé in 2007 and is headquartered in Munich, Germany.

See how Formycon AG is moving with its highest-yielding bonds.
Advanced bond data for paid plans
Unlock important bond data including coupon rates, redemption details, risk assessments, and much more.